PDCD1 and cancer: These were activated with a combination of CD3/28 beads (to mimic a chronic activation conditions) together with either anti-PD-1 mAb or fusion protein after which the CTLs were co-incubated with peptide pulsed PD-L1 (+) cancer cells.